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The! second! part! of! this! thesis! was! a! study! into! the! usefulness! of! alginates! in! the!
prevention!and!treatment!of!colorectal!cancer.!Project!Two!aimed!to!investigate!the!in,
vitro!effects!of!alginateWbound! iron!on!cellular!phenotype! in!comparison! to! iron!only!
















This! thesis! is! dedicated! to!my!wonderful! family,! partner! and! friends! for!
































Despite! wellWestablished! treatment! plans! being! in! place,! tuberculosis,! an! infectious!
disease!caused!by!the!bacteria!Mycobacterium,tuberculosis,! is!still!one!of!the!leading!
causes!of!death!worldwide.!The!rise!of!multidrug!and!extensively!drugWresistant!strains!
especially! in! the! developing! countries! calls! for! new,! more! efficient! and! affordable!
antitubercular!drugs.!The!M.,tuberculosis!protein!DprE1!has!recently!been!identified!to!
be! the! target! of! several! new! drug! compounds.! In! this! study,! two! promising! DprE1!
inhibitors! structurally! different! to! representatives! of! the! currently! leading! groups,!






measuring! inherent! tryptophan! fluorescence.! Single! ligand,! competition! and!mutant!










Einstein! College! of!Medicine! (William! R.! Jacob! group)! for! providing! the! ligands! and!
therefore!the!basis!of!my!study.!
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AG! ! ! Arabinogalactan!
Bmax! ! ! Maximum!binding!capacity!
BSA! ! ! Bovine!serum!albumin!
BTZs! ! ! Benzothiazinones'
CV! ! ! Column!volumes!
diH2O! ! ! Distilled!water!
DMSO! ! ! Dimethyl!sulfoxide!
DNBs! ! ! Dinitrobenzamides!
DPA! ! ! DecaprenylphosphorylW!βWDWarabinose!
DPR! ! ! DecaprenylphosphorylW!βWDWribose!
DPX! ! ! DecaprenylphosphorylW2WketoWβWDWerythroWpentofuranose!
DR! ! ! DrugWresistant!
E.,coli, , , Escherichia,coli,
FAD!! ! ! Flavin!adenine!dinucleotide!
HCl! ! ! Hydrochloric!acid!
HIV! ! ! Human!immunodeficiency!virus!
IPTG! ! ! IsopropylWβWDWthiogalactopyranosid!
Kd! ! ! Dissociation!constant!
LAM! ! ! Lipoarabinomannan!
LB!! ! ! Luria!Bertani!
mAGP! ! ! MycolylWarabinogalactanWpeptidoglycan!
MDR! ! ! MultidrugWresistant!
MIC! ! ! Minimal!inhibitory!concentration!
M.,tuberculosis, Mycobacterium,tuberculosis!
O.C.! ! ! Overnight!culture!
NaOH! ! ! Sodium!hydroxide!
SDS! ! ! Sodium!dodecyl!sulphate!
TB! ! ! Tuberculosis!
TDR! ! ! Totally!drugWresistant!
Trp! ! ! Tryptophan!
WHO! ! ! World!Health!Organization!






Tuberculosis! (TB)! is! a! chronic! infectious! disease! caused! by! the! airborne! pathogen!
Mycobacterium, tuberculosis! (M., tuberculosis)! (Neres! et, al.! 2012).! According! to! the!
World!Health!Organization!(WHO),! in!86%!of!cases!worldwide!M.,tuberculosis,causes!
pulmonary! TB,! where! the! infection! is! localised! in! the! lungs.! The! bacteria! enter! the!










were! also! infected!with! the! human! immunodeficiency! virus! (HIV).! In! the! same! year,!
there!was!an!estimated!1.4!million!deaths! caused!by!TB,!overall! affecting! just!under!
one!million!HIVWnegative!and!nearly!half!a!million!HIVWpositive!individuals!(WHO!2012).!
!
The! spread! of! this! disease! is! promoted,! especially! in! developing! countries,! due! to!






being! treated! sufficiently! (WHO! 2012).! However,! not! only! the! developing! countries!
carry!the!burden!of!this!disease.!In!our!modern!world,!where!fast!transport!and!open!




The! current!multiWdrug! standard! regimen! for! patients! infected!with! drugWsusceptible!
TB!suggested!by!the!WHO!includes!the!use!of!the!frontWline!drugs!isoniazid,!rifampicin,!
pyrazinamide! and! ethambutol! for! two!months! followed! by! four!months! of! isoniazid!




We! distinguish! between! multidrugWresistant! (MDR),! extensively! drugWresistant! (XDR)!
and! recently! even! so! called! “superWXDR! strains”! (Pasca! et, al.! 2010,! Cole! &! Riccardi!
2011).! MDR! is! defined! as! resistance! against! both! front! line! drugs! isoniazid! and!
rifampicin.! It! is! estimated! that! 3.7%!of! newly! infected! individuals! and! between! 15%!
and!20%!of!patients,!who!have!been!previously!treated!for!TB,!carry!MDR!strains.!Even!






worldwide,! the!estimated!number!of!unreported!MDR!cases! is!especially!high! (WHO!
2010,!WHO! 2012).! The! current! treatment! regimen! for!MDRWTB! lasts! at! least! twenty!
months! and! uses! expensive! but! less! efficient! secondWline! drugs! such! as!
fluoroquinolone,! aminoglycosides! and! ethionamide! (Cole! &! Riccardi! 2011).! These!




patient! compliance! (Field! et, al.! 2012).! This! favours! the! development! of! further!
resistances!and!according! to! the!WHO,!XDR!strains!were! reported! in!84! countries! in!
2011!(Villemagne!et,al.!2012,!WHO!2012).!XDR!strains!are!defined!as!MDR!strains!with!
additional! resistance! to! fluoroquinolones!and! injectable!antibiotics! such!as!amikacin,!
kanamycin!and!capreomycin!(Velayati!et,al.!2009,!Field!et,al.!2012).!
!
Even! more! worrying! than! the! rise! in! XDRWTB! cases,! are! the! news! about! soWcalled!
“superWXDR”!or!totally!drugWresistant!(TDR)!strains!that!have!recently!been!reported!in!
Iran! and! India.! Velayati! et, al.! (2009)! and! Udwadia! et, al.! (2012)! described! the! TDR!
strains!isolated!in!their!studies!as!MDR!strains!with!resistance!to!all!first!and!secondW






of! their! patients! and! therefore,! possible! previous! treatments!with! secondWline! drugs!
for!respiratory!diseases!other!than!TB!(Velayati!et,al.!2009,!Udwadia!et,al.!2012).!
!











and! they! should! be! available! at! a! low! cost! to! be! accessible! for! patients! in! the!
developing!countries.!Finally,! the!drugs!should!be!effective!against!both!growing!and!
dormant! TB! bacilli,! as! antibiotics! treatment! using! an! inhibitor! that! prevents! growth!
only!tends!to!drive!the!infection!into!the!latent!state!without!full!clearance.!Latent!TB!







many! promising! new! drug! candidates! as! there! are! at! the!moment! (Cole! &! Riccardi!
2011,!Field!et,al.!2012).!Eleven!compounds,!some!targeting!entirely!new!drug!targets!
and! some! being! repurposed! tuberculosis! drugs,! are! currently! in! different! stages! of!
clinical! trials! (Lienhardt!et,al.! 2012).!However,! it! is! not! known!whether! any!of! these!




Mycobacteria,! in! comparison! to! gramWnegative! and! gramWpositive! bacteria,! have! a!
unique! hydrophobic! cell! wall! structure.! It! forms! the! barrier! between! host! and!






As! shown! in! figure! 1,! the! mycobacterial! cell! wall! can! be! divided! into! three! major!
sections,!the!plasma!membrane!on!the! inside,!the!soWcalled!mycolylWarabinogalactanW







mycobacterial! cell! wall.! AG! acts! as! a! covalent! linker! between! the! crossWlinked!
peptidoglycan! and! the! outer! layer! of! mycolic! acids! (Alderwick! et, al.! 2011,! Cole! &!




Overall,! arabinan!accounts! for!18%!of! the!mycobacterial! cell!wall! and! is! the!building!




Besides! its! structural! role! (figure!1),! LAM! is! an!essential!M., tuberculosis, immunogen!
that!is!part!of!the!cells!protective!mechanism!against!host!toxins!and!allows!interaction!
with! the! host! cell! (Alderwick! et, al.! 2011).! It! has! been! found! that! the! molecule!
decaprenylphosphorylWβWDWarabinose! (DPA)! is! the! sole! known! precursor! of!
mycobacterial! cell!wall! arabinan!and! is! therefore! crucial! for! the! synthesis!of!AG!and!
LAM!(Pasca!et,al.!2010,!Neres!et,al.!2012).!The!conversion!of!decaprenylphosphorylWβW
DWribose! (DPR)! to! DPA! is! catalysed! by! the! DprE1! catalytic! subunit! of! the! enzyme!
decaprenylphosphorylWβWDWriboseW2’Wepimerase!together!with!its!partner!DprE2!(Pasca!
et,al.!2010).!The!epimerase!is!encoded!by!the!neighbouring!genes!dprE1!(Rv3790)!and!




the! periplasmic! side! of! the! plasma!membrane! (LarrouyWMaumus!et, al.! 2012).! In! the!
cytoplasm,!DPR!is!oxidised!by!DprE1!to!the!intermediate!decaprenylphosphorylW2WketoW









thought! to! work! as! a! DPA! translocase! thus! moving! it! from! the! cytoplasm! to! the!
periplasm!for!further!synthesis!into!AG!and!LAM. 
1.3.2'DprE1'as'TB'drug'target'
Without! DPA,! a! fully! functional! cell! wall! cannot! be! formed,! making! it! essential! for!
mycobacterial! growth! (Cole! &! Riccardi! 2011,! Crellin! et, al.! 2011).! It! is! therefore! not!







DprE1! works! as! a! decaprenylphosphorylWβWDWribose! oxidoreductase! with! a! flavin!
adenine!dinucleotide!(FAD)!as!redoxWactive!component!(Alderwick!et,al.!2011,!Batt!et,
al.! 2012).! The! dprE1! gene! is! highly! conserved! among! mycobacteria! supporting! the!
statement!that!DprE1!is!essential!for!mycobacterial!survival!(Neres!et,al.!2012).!The!50!
kDa!protein!has!a!twoWdomain!structure!with!an!FADWbinding!domain!and!a!substrateW
binding! domain.! It! has! structural! similarities! with! proteins! from! the! vanillylWalcohol!












BTZ043! (figure! 4).! It! has! nanomolar! wholeWcell! activity! with! a! minimal! inhibitory!













benzoquinoxalines.! DNB1! (figure! 4)! has! been! proven! to! be! effective! against! drugW








that! also! target!DprE1.! The! knowledge! about! the! active! side! of! the! protein! and! the!




Two!new! ligands! targeting!DprE1,!designed!by!The!Scripps!Research! Institute! (group!
leader!Peter!Schulz)!and!the!Albert!Einstein!College!of!Medicine!(group!leader!William!
R! Jacobs’s),! were! provided! for! this! study.! Besides! genetic! evidence! proving! their!
activity,!the!ligands!C12!and!RKH06!were!both!identified!in!wholeWcell!assays!to!target!
DprE1.!They!are!structurally!different!from!BTZs!and!DNBs!and!also!employ!a!different!





and! latent! TB,! however! in! terms!of! potency,! it! is! still! distinctly!weaker! than!BTZ043!
(unpublished!data!P.!Schulz!group).!
!
The! K.! Fütterer! group! coWcrystallised! DprE1! with! the! ligands! and! it! was! possible! to!





FAD! coWfactor,! thus! inhibiting! any! turnover! of! substrate.! RKH06! on! the! other! hand!





























in! the! development! of! any! new! drug! compound,! it! is! crucial! to! investigate! and!
understand! its! mode! of! action! in! order! to,! for! instance! increase! its! affinity! to! the!
target,!or!to!side!step!know!resistanceWconferring!mechanisms.!Therefore,!to!ascertain!









of!both! ligands.!This!was! followed!by!competition!experiments! to!assess! the!binding!
behaviour!of!each!ligand!in!presence!of!the!other!ligand!at!its!Kd.!
!







The!chemicals!and!other! ingredients!mentioned! in! this! section!were!purchased! from!
SigmaWAldrich! Company! Ltd! or! Fisher! Scientific! UK! Ltd! unless! stated! otherwise.! The!










Using! the! MiniWPROTEAN! Tetra! handcast! system! (BIOWRAD),! SDSWPAGE! gels! were!
prepared!fresh.!To!cast!a!gel,!all!bottom!gel!ingredients!were!mixed!according!to!table!
1!and!poured!between! the!glass!plates.! To!achieve!an!even! surface,!2Wbuthanol!was!
added! dropWwise! to! cover! the! gel.! After! leaving! the! gel! to! set,! the! 2Wbuthanol! was!













For#two#gels#à#5#ml:# 10%$ 12%$ Top$gel$
diH2O# 4#ml# 3.3#ml# 2.7#ml#
Gel#buffer#(I)#or#(II)# 2.5#ml#(I)# 2.5#ml#(I)# 500#µl#(II)#
Polyacrylamide# 3.3#ml# 4#ml# 670#µl#
10%#SDS# 100#µl# 100#µl# 40#µl#
10%#ammonium#persulfate# 100#µl# 100#µl# 40#µl#




The# stain#was# removed#and# the# gels#were#placed# in#destain# for# 20# to#30#minutes.# If#
necessary,#the#destain#was#changed#after#this#time#before#examining#the#gels.#
2.2$Protein$overexpression$protocol$
The# following# protocol#was# carried# out# under# sterile# conditions.# Benches# and# hands#
were# cleaned# using# 70%# ethanol# and# all# equipment# including# pipette# tips# were#
sterilised#with#a#Bunsen#burner#before#use.# The#plasmid#and#Escherichia' coli# (E.' coli)#





Unless!the!agar!was!used!straight!after!autoclaving,! it!was!completely! liquefied! in!an!
microwave! oven! and! then! left! to! cool! down! to! about! 55°C! before! adding! the!
appropriate! antibiotics! for! a! final! concentration! of! 100! μg/ml! ampicillin! and!





























Finally,! 25! μl! and! 350! μl! of! culture! were! plated! on! LB! agar! supplemented!with! the!
appropriate! antibiotics! (see! table! 2)! and! 1%! glucose.! The! plates! were! incubated!
overnight!at!37°C.!
!





Rv3790' Chaperone' Ratio' Host'
pet28b! pTrcW60.2WGroES! 1:1! E.,coli!BL21!(DE3)!




a! final! concentration! of! 100! μg/ml! ampicillin! and! spectinomycin! and! 50! μg/ml!
























A! sample! of! induced! cells! was! taken.! To! harvest! the! pellet,! the! bulk! culture! was!
transferred! into!centrifuge!bottles!and!was!spun!for!10!minutes!at!5000!RPM!at!4°C.!
The!pellets!were!transferred!into!50!ml!tubes!and!the!bottles!were!rinsed!with!15!ml!
0.85%! saline! wash! buffer.! This! was! added! to! the! tubes! and! the! pellets! were!
centrifuged! for! 10! minutes! at! 5000! RPM! at! 4°C.! The! saline! was! discarded! and! the!






To! lyse! the! cells,! the! resuspended!pellet!was! sonicated!on! ice! for! a! total! time!of!10!





A! 1! ml! Ni2+Wcharged! HisTrap! HP! column! (GE! Healthcare)! was! used! together! with! a!
Minipuls! 3! pump! (Gilson)! for! the! first! purification! step.! The! flow! rate! was! set! at! 1!
ml/minute!and!the!column!was!equilibrated!with!20!column!volumes!(CV)!buffer!A!10!
mM! imidazole.! The! filtered! clear! lysate! was! loaded! onto! the! column! and! the! flow!
through!was!collected.!The!column!was!washed!with!10!CV!buffer!A!10!mM!imidazole!
and!the!protein!was!eluted!with!a!gradient!of!10!mM,!20!mM,!40!mM,!60!mM,!80!mM,!
100! mM,! 200! mM! and! 300! mM! imidazole! using! 10! CV! each.! The! elutions! were!
collected!in!individual!tubes!and!kept!at!4°C.!
2.3.4'SDSZPAGE'gel'










chilled! dialysis! buffer.! The! membrane! was! closed! with! clips! to! form! a! bag! before!
adding!the!protein.!Fractions!identified!on!the!SDSWPAGE!gels!were!dialysed!overnight!





(GE! Healthcare)! was! used! together! with! a!Minipuls! 3! pump! (Gilson)! for! the! second!












The! absorbance! of! the! dialysed! solution!was! determined!with! the! NanoDrop! 2000c!
Spectrophotometer! (Thermo!Scientific).!Buffer!B!10!mM!NaCl!was!used!as!blank!and!



















solution!was! loaded! into! the! filter! and! spun! for! 25!minutes! at! 7000xg! and! 4°C.! The!















































the! impact!of!photobleaching!on! the!protein,!a! test!measurement!using!0.5!μM!BSA!






All! ligands! for! this! project!were! provided! by! The! Scripps! Research! Institute! and! the!
Albert!Einstein!College!of!Medicine.!Ligand!C12!(molecular!weight:!375.42!g/mol)!and!
RKH06!(molecular!weight:!418.47!g/mol)!were!made!up!to!20!μM!and!500!μM!working!
stocks! in! 100%! dimethyl! sulfoxide! (DMSO).! Experiments! using! 20! μM! stocks! were!






































Buffer' 583.7!' 74' 2.01!/!16.3!' 0.5!/!0.6'
DMSO' 583.7' 74' 2.01!/!16.3' 0.5!/!0.6'
Single!ligand! 574! 47!! 2.04!/!26! 0.51!/!0.61!
Competition! 573.2! 45! 2.01!/!26.8! 0.5!/!0.6!
Control!–RKH06! 597.6! 509! 2.04!/!2.4! 0.51!/!0.61!
Control!–!C12! 597.3! 450! 2.0!/!2.67! 0.5!/!0.6!
2.5.7'Buffer'and'DMSO'control'measurements'
To! determine! the! effect! of! buffer! and!DMSO! additions! on! the! protein! fluorescence,!
control!measurements!were! performed.! To! be! able! to! compare! the! results!with! the!
ligand! titrations,!DMSO!and!buffer!were!added! in! the!same!quantities!as! the! ligands!
would! be! added! and! ‘ligand! concentration’! was! used! as! a! unit! for! buffer! or! DMSO!
concentration.! This! refers! to! the! volume! of! buffer! or! DMSO! added! to! achieve! a!
particular!ligand!concentration.!
!
The! appropriate! amount! of! buffer! (table! 4)! was! added! to! the! cuvette! and! a!
measurement!was!taken!immediately.!Wild!type!DprE1!was!added!according!to!table!4!
and! the! fluorescence! was! measured! immediately! (DprE1_0).! Then! the! light! was!
blocked!out! in! front!of! the!cuvette! to! reduce!photobleaching.!Further! readings!were!
taken!after! two!and! four!minutes! (DprE1_2!and!DprE1_4)! and! the! light!was!blocked!
out!in!between!readings.!The!light!was!always!blocked!out!after!taking!a!measurement!


















Buffer!only! W! W! W! 32!
DprE1_0! W! W! W! 923!
DprE1_2! W! W! W! 915!
DprE1_4! W! W! W! 908!
DprE1!with!buffer!/!
DMSO!only!
0.5! 0.6! 0.6! 899!
WWW“WWWWWW“WWWWWW“WWW! 4.5! 4.8! 5.49! 876!
'
2.5.8'Single'ligand'experiments'
The! protocol! for! measuring! DprE1! with! a! single! ligand! was! the! same! as! described!
under!2.5.7,!however,!instead!of!adding!buffer!or!DMSO!after!measurement!DprE1_4,!
either! C12! or! RKH06! was! added.! For! the! initial! experiments,! three! replicates! were!




The! buffer! and! DprE1! only! measurements! were! undertaken! in! the! same! way! as!




This! was! the! only! addition! of! ligand! A! and! therefore! the! concentration! of! ligand! A!















Buffer!only! W! W! W! 32!
DprE1_0! W! W! W! 923!
DprE1_2! W! W! W! 915!
DprE1_4! W! W! W! 908!
DprE1!with!ligand! 0.51! 0.61! 0.6! 900!











Buffer!only! W! W! W! 32!
DprE1_0! W! W! W! 923!
DprE1_2! W! W! W! 915!
DprE1_4! W! W! W! 908!
DprE1!with!ligand!A! W! W! W! 520!
DprE1!with!ligands!A!
&!B!
0.5! 0.6! 0.6! 450!





The! data! for! each! experiment! was! recorded! as! shown! in! tables! 5,! 6! and! 7.! Using!
Microsoft! Excel! for! Mac! 2011,! the! data! was! analysed! and! recorded! as! saturation!
binding! curves! based! on! the! fluorescence! quenching! caused! by! ligand! binding.! To!
determine! the! maximum! binding! capacity! (Bmax)! and! dissociation! constant! (Kd),! the!














































was! resuspended!with!250!μl!buffer!P1!and! transferred! into!a!microcentrifuge! tube.!
Buffer!P2!(250!μl)!was!added!and!the!solution!was!mixed!thoroughly!by!inverting!the!
tube! several! times.! Buffer! N3! (350! μl)! was! added! and! the! solution! was! mixed!
immediately!by! inverting!the!tube!several!times.!This!was!centrifuged!for!10!minutes!
at!14,000!RPM.!The!supernatant!was!transferred!into!a!QIAprep!spin!column!and!this!



















Mutation! R242A! E294A! Y297A! R242A! E294A! Y297A!
Reaction!buffer! 5!μl! 5!μl! 5!μl! 5!μl! 5!μl! 5!μl!
Plasmid! 3!μl! 3!μl! 3!μl! 1!μl! 1!μl! 1!μl!
Primer_F! 1!μl! 1.1!μl! 1!μl! 1!μl! 1.1!μl! 1!μl!
Primer_R! 1!μl! 1.1!μl! 1!μl! 1!μl! 1.1!μl! 1!μl!
dNTP! 1!μl! 1!μl! 1!μl! 1!μl! 1!μl! 1!μl!
DMSO! 2.5!μl! 2.5!μl! 2.5!μl! 2.5!μl! 2.5!μl! 2.5!μl!
H2O! 35.5!μl! 35.3!μl! 35.5!μl! 37.5!μl! 37.3!μl! 37.5!μl!
Pfu!Turbo!Cx!
Polymerase!










! ! ! ! ! 2!min/kb!for!6W10!kb!genomic!template!!









1! 1! 95°C! 1!min! 1!min!
2! 16! 95°C! 30!sec! 30!sec!
3! 16! 72°C! 13!min!24!sec! 5!min!6!sec!
!
After!temperature!cycling,!the!reactions!were!cooled!down!to!37°C!before!adding!1!μl!
of!Dpn! I! restriction! enzyme! (Agilent! Technologies).! The! reactions!were! incubated! at!
37°C! for! one! hour! to! digest! the! parental! supercoiled! plasmid! DNA.! E., coli! Top10!
competent!cells!were!transformed!with!the!PCR!products!(see!2.2.2).!
2.7.4'SmallZscale'expression'series'
The! plasmid! DNA! from! four! colonies! from! each! transformation! plate! was! extracted!






The# O.C.s# that# grew# successfully# were# used# to# inoculate# 10# ml# Terrific# Broth# bulk#
cultures# (see# 2.2.5).# To# check# the# expression# of# each# mutant# before# sequencing,#
samples# of# cells# before# and# after# induction#with# IPTG#were# run# on# an# SDSKPAGE# gel#
(see#2.1).#
2.7.5%Sequencing%




The# mutations# were# successful# in# all# sequenced# plasmids.# The# Rv3790KpCDF# duet#
E294A# and# Y297A# sequenced# plasmids# were# transformed# into# E.' coli# BL21# (DE3)#






















550! 24! 2.0!/!50! 0.5!/!0.6!
DprE1!mutant!
E294A!–!C12!
540! 20! 2.0!/!60! 0.5!/!0.6!
DprE1!mutant!
Y297A!–!RKH06!
565.7! 35! 2.0!/!34.3! 0.5!/!0.6!
DprE1!mutant!
Y297A!–!C12!








from! transformations! with! Rv3790WpCDF! and! pTrcW60.2WGroES! grown! in! LB! medium!




chaperone! affects! DprE1! expression,! Rv3790WpCDF! duet! and! pTrcW60.2WGroES! were!
transformed! in! E., coli! BL21! (DE3)! competent! cells! in! 3:1! and! 1:3! ratios.! These!
transformations!were!grown!in!LB!medium!and!the!protein!expression!was!induced!by!
adding! IPTG!for!a! final!concentration!of!0.2!mM.! It!was!observed!that! the!1:3! (more!




the! crude! lysate.! Both! ratio! transformations! produced! more! protein! than! the! 1:1!
transformation.! Also,! the! chaperone! was! expressed! in! much! higher! quantities! than!
DprE1! in! both! ratio! transformations! and! it! was! expressed! stronger! than! in! the! 1:1!








after, IPTG, induction, from, a, 1:1, transformation, as, reference.,Molecular,masses, are, given, in,
units,of,kDa.,
3.3'Successful'expression'and'purification'of'wild'type'DprE1'
Transformations! using! Rv3790WpCDF! duet! together! with! the! chaperone! pTrcW60.2W
GroES! grown! in! Terrific! Broth! were! always! successful! and! produced! reasonable!
quantities!of!soluble!DprE1.!
!
The! gel! in! figure! 7! shows! samples! taken! throughout! the! expression! and! HisTrap!
chromatography! purification! process! of! wild! type,DprE1.! DprE1! and! the! chaperone!
Cpn60.2!were! both! strongly! expressed! after! IPTG! induction! and! carried! through! the!
crude!into!the!clear!lysate.!The!chaperone!was!mostly!retained!in!the!flow!through!and!








HisTrap, chromatography, purification, process, of, wild, type, DprE1., From, left, to, right, the, gel,
shows,the,molecular,marker,,cells,before,IPTG,induction,(T),,cells,after,IPTG,induction,(+),,crude,
lysate,, clear, lysate,, HisTrap, column, flow, through, (FT), and, elutions, with, imidazole,
concentrations,given,in,mM.,Molecular,masses,are,given,in,units,of,kDa.,
 






Fig., 8:, CoomassieTstained, SDSTPAGE, gel, showing, elution, samples, taken, throughout, the, ion,




















Given! that! the! structure! of! DprE1! has! been! known! (figure! 5),! it! was! reasonable! to!
expect!that!an!inhibitor!of!this!enzyme!should!bind!in!the!binding!pocket!next!to!the!
flavin.!However,!it!is!conceivable!that!an!inhibitor!is!uncompetitive!or!nonWcompetitive,!










This!was! followed!by! single! ligand!experiments! to! determine! the!Kd! of! both! ligands.!
Then,! to! either! support! or! disprove! the! crystallographic! evidence,! competition!
experiments!with!both! ligands!were!performed.!Finally,! to!confirm!the!results!of! the!
initial! single! ligand! measurements,! control! measurements! using! protein! from! a!





normalised! data! in! order! to! allow! comparison! between! individual! experiments! on! a!









variation! in! this! study).!This!demonstrates! the!variation!of! replicates!and!shows! that!
the!average!binding!curve!is!a!good!representative!of!the!individual!replicates.!
3.4.1'Buffer'and'DMSO'control'measurements'
To! determine! the! effect! of! buffer! and/or! DMSO! additions! on! the! Trp! fluorescence!








DMSO! up! to! a! concentration! equivalent! to! 68.5! μM! of! ligand.! After! that,! the!
fluorescence! reaches! a! plateau! for! buffer! and! decreases! linearly! for! DMSO.! This!























a#mean#Bmax# of# 965.5#while# RKH06#had# a#mean#Kd# of# 15.19#μM#and# a#mean#Bmax# of#
1053.6#(table#12).#
3.4.3%Competition%experiments%
To# determine#whether# the# ligands# are# binding# in# different# sites# or# compete# for# the#












Figure# 14# shows# two# example# fluorimeter# spectra# of# one# competition# experiment#
measurement#where#C12#was#titrated#onto#15#μM#RKH06#and#RKH06#was#titrated#onto#






for# each# condition.# To# be# able# to#monitor# any# effects# of# degradation# on# the# ligand#
binding#affinity,#the#protein#age#was#recorded#from#the#day#of#HisTrap#purification.#The#










Wild#type#–#buffer# 74# V# # 7#
Wild#type#–#DMSO# 74# V# # 7#
Wild#type#–#RKH06# 47# 15.19# 1053.6# 17#
Wild#type#–#C12# 47# 7.41# 965.5# 18#
Wild#type#–#RKH06#with#7.5#μM#C12# 45# 24.28# 635.6# 19#
Wild#type#–#C12#with#15#μM#RKH06# 45# 13.73# 381.7# 20#
Mutant#Y297A#–#RKH06# 35# 8.63# 660.4# 6#
Mutant#Y297A#–#C12# 35# 4.89# 657.8# 7#
Mutant#E294A#–#RKH06# 24# 10.60# 702.0# 8#
























To# confirm# the# results# of# the# initial# single# ligand# measurements,# two# control#




control# measurement# with# C12# and# RKH06.# To# be# able# to# monitor# any# effects# of#
degradation#on#the#ligand#binding#affinity,#the#protein#age#was#recorded#from#the#day#




control# measurement# was# only# performed# after# the# protein# was# 15# days# old.# Two#
independent#measurements#were#taken#for#each#ligand#on#different#days.#
#
Table' 13:' Information' on' stock' concentration,' Kd' and' protein' age' for' the' wild' type' DprE1'
control'measurements'
Set$up$ Stock$conc.$(μM)$ Kd$(μM)$ Protein$age$
Wild#type#–#C12#control#one# 599# 8.7338# 15#days#
Wild#type#–#RKH06#control#one# 509# 32.2064# 23#days#
Wild#type#–#C12#control#two# 450# 20.9345# 28#days#













(figure# 5)# were# designed# in# both# Rv3790EpET28b# and# RvE3790EpCDF# duet.# These#




chosen# for# further# ligand# binding# studies.# Both# DprE1# mutants# were# successfully#
expressed#and#purified#and#produced#adequate#quantities#of#pure#soluble#protein.#
#






The# gel# in# figure# 18# shows# samples# taken# throughout# the# expression# and# HisTrap#
chromatography# purification# process# of# E294A# mutant# DprE1.# E294A# mutant# DprE1#
was#expressed#after#IPTG#induction#and#carried#through#the#crude#into#the#clear#lysate.#
Protein# was# present# in# the# 20#mM,# 100#mM# and# 200#mM# elutions,# however# these#




Fig.' 18:' CoomassiePstained' SDSPPAGE' gel' showing' samples' taken' throughout' the' expression'
and'HisTrap'chromatography'purification'process'of'recombinant'E294A'mutant'DprE1.'From'
left'to'right'the'gel'shows'the'molecular'marker,'cells'before'IPTG'induction'(P),'cells'after'IPTG'





The# gel# in# figure# 19# shows# the# ion# exchange# chromatography# elutions# with# NaCl#





E294A# mutant# DprE1# was# present# in# the# 140# mM# to# 1# M# elutions.# However,# pure#
protein#without# contaminations#was# only# present# in# the# 160#mM,# 180#mM#and# 200#
mM#elutions,#which#were#dialysed#together.#
#
Fig.' 19:' CoomassiePstained' SDSPPAGE' gel' showing' elution' samples' taken' throughout' the' ion'








The# gel# in# figure# 20# shows# samples# taken# throughout# the# expression# and# HisTrap#









Fig.' 20:' CoomassiePstained' SDSPPAGE' gel' showing' samples' taken' throughout' the' expression'
and'HisTrap'chromatography'purification'process'of'recombinant'Y297A'mutant'DprE1.'From'
left'to'right'the'gel'shows'the'molecular'marker,'cells'before'IPTG'induction'(P),'cells'after'IPTG'





The# gel# in# figure# 21# shows# the# ion# exchange# chromatography# elutions# with# NaCl#








Fig.' 21:' CoomassiePstained' SDSPPAGE' gel' showing' elution' samples' taken' throughout' the' ion'








To#check# the#purity#and# state#of# the#mutated#proteins#after# concentrating#with#a#10#
kDa# cutEoff# filter,# concentrated# E294A# and# Y297A#mutant# DprE1# and# 1:10,# 1:20# and#
1:50#dilutions#were#run#on#a#gel#(figure#22).#Even#though#there#was#some#degradation#

















Given#the#crystallographic#evidence# (figure#5),# the#hypothesis# for# the#mutant#binding#
studies#was#that# if#RKH06#binds# in#the#site#shown#in#the#crystal#structure#then#the#Kd#




normalised# data# in# order# to# allow# comparison# between# individual# experiments# on# a#
scale# from#1# to# 100# independent# from#Bmax.# The#binding# curves# represent# the#mean#
value#obtained#for#each#experiment.#
#
As# for# the# wild# type# DprE1# experiments,# the# ligands# were# gradually# added# to# the#
protein#starting#at#0.5#μM#up#to#a#final#concentration#of#68.5#μM.#
#






























XIray# crystallography,# the# technique# which# allows# the# construction# of# protein#
structures,#relies#on#the#principle#of#crystal#lattice#formation#from#highly#concentrated#
protein.# However,# a# crystal# lattice# does# not# represent# the# physiological# state# of# the#
protein#and#can#cause#changes# in# the#proteins#properties.# In#order# to# form#a#crystal,#
there# has# to# be# sufficient# contact# between# the# molecules.# The# tight# interaction#
between# the#molecules#due# to# the#pressure# in# the# lattice#can# induce#conformational#
changes,#which# in# turn# can# alter# the# binding# affinity# of# the# protein.# Even# very# small#
conformational# changes# can#have# great# impact# on# the#binding# affinity.# Furthermore,#
the#protein#concentration#in#a#crystal#is#very#high#with#values#around#12.5#μM#whereas#
the#physiological# protein# concentration# in# cells# is# about# three# times# lower.# This#high#
concentration#of#protein#can#also#cause#changes#in#binding#behaviour.#Therefore,#it#can#
happen# that# the# evidence# provided# by# XIray# crystallography# does# not# capture# the#
binding#behaviour#that#the#protein#would#show#in'vivo#or#in#solution.#
#
At# a# minimum,# the# ligandIbound# crystal# structure# indicates# that# DprE1# offers# an#














is# an# arbitrary# value# depending# on# the# instrument# and# unit# used# for#measuring# the#
fluorescence.#The#Kd#value#is#used#to#determine#the#binding#affinity#and#represents#the#
ligand# concentration# at#which# half# of# the#maximum# binding# sites# are# occupied.# It# is#
given#in#M#(Lambert#2004).#
#
To# determine# any# background# noise# or# effect# on# the# Trp# fluorescence# before#
undertaking#any#binding#studies,#control#measurements#with#DprE1#and#buffer#/#DMSO#
were#performed.#As# shown# in# figure# 11,# gradual# decrease# in# fluorescence#with# each#
buffer#/#DMSO#addition#was#observed.#This#can#be#explained#by#the#fact#that#with#each#
addition# the# volume# in# the# cuvette# expands# which# causes# a# decrease# in# protein#






an# equivalent# ligand# concentration# of# 68.5# μM.#Given# that# the# fluorescence# of# both#
was# so# low,# no# effect# on# the# protein# was# suspected.# However,# after# the# 68.5# μM#
addition# it#seems#that# the#effect#of#buffer#and#DMSO#becomes#unpredictable.#This# is#
especially#noticeable#in#the#fluorescence#spectrum#example#for#DMSO#(figure#11).#The#
last# three# additions# equivalent# to# 68.5# μM,# 108.5# μM# and# 148.5# μM# ligand#
concentration# caused# a# fluorescence# peak# at# about# 305# nm,#which#was# not# the# Trp#
















To# confirm# the# results# of# the# initial# single# ligand# experiments,# two# control#
measurements# for# each# ligand# were# performed# with# DprE1# from# a# different#
transformation.#The#control#measurements#for#C12#were#performed#when#the#protein#
was# 15# and# 28# days# old.# The# Kd# for# first#measurement#was# 8.73# μM# and# the# Kd# for#
second#measurement#was# 20.93# μM.# The# Kd# of# the# second#measurement#was#more#
than# two# times# higher#which# looking# at# figure# 16# is# shown# by# a# drastic# shift# of# the#
curve.# Comparing# the# two# measurements,# the# Kd# of# the# second# measurement# was#
























To# determine#whether# the# ligands# are# binding# in# different# sites# or# compete# for# the#










The# Kd# was# about# 1.85# times# higher# than# that# of# C12# on# its# own# and# there# was# a#
difference#of#6.32#μM#between#these#values.#Looking#at#figure#15,#there#is#an#obvious#





The# Kd#was# about# 1.6# times# higher# than# that# of# RKH06# on# its# own# and# there#was# a#
difference# of# 9.08# μM# between# these# values.# This# explains# the# obvious# difference#





suggest# that# the# ligands# have# to# compete# for# one# binding# site.#With# the# first# ligand#





further# studies# were# needed# to# obtain# more# information# on# the# protein’s# binding#
behaviour.#Therefore,#two#single#amino#acid#change#DprE1#E294A#and#Y297A#mutants#
















657.8.# Compared# to# that,# the#mean# Kd# of#wild# type#DprE1#with# C12#was# about# 1.51#
times# higher# and# there# was# a# difference# of# 2.52# μM# between# the# values.# This# is#
illustrated#by#the#small#shift#in#the#saturation#binding#curves#(figure#25).#
#
Looking#at# the#binding#affinity#of# the#DprE1#mutants#with#C12# in#comparison# to#wild#





was# 702.0.# In# comparison# to# that,# the#mean# Kd# of#wild# type#DprE1#with# RKH06#was#
about# 1.43# times# higher# and# there# was# a# difference# of# 4.59# μM# between# the# two#











mutant# decreased# by# nearly# two# fold.# There# was# a# very# definite# shift# in# curve# also#
comparable# to# the# competition# experiments.# This# significant# change# in# Kd# was# not#




A# possible# explanation# is# that# single# amino# acid# changes# can#have# an# impact# on# the#
structure# and# therefore# the# behaviour# of# the# protein,#which#may# not# be# obvious# or#
predictable#from#looking#at#the#DNA#sequence.#Generally,#50%#to#80%#of#residues#can#





disordered# residues,# can#have# an#unexpected# effect# on# the#proteins# conformation# it#
might#be#that#the#Y297A#mutation#resulted#in#a#conformational#change#that#caused#the#









C12.# As# explained# above,# the# change# in# Kd# could# be# due# to# the# effect# of# the# single#
amino# acid# mutation# on# the# protein# but# this# cannot# be# said# with# certainty.#







The# methods# used# to# measure# the# ligand# binding# affinity# of# DprE1# had# several#
limitations.# Firstly,# the# machine# used# for# the# measurements# was# a# Perkin# Elmer#
Luminescence# Spectrometer# LS# 50B# with# a# 10W# lamp.# The# machine# represents# the#
protein#fluorescence#on#an#arbitrary#scale#from#0#to#1000#with#no#units.#The#problem#
















used.#Given# the# impact# age#had#on# the#wild# type#DprE1# control#measurements,# it# is#







To# ensure# a# constant# protein# concentration# for# all#measurements,# any# precipitation#
was# removed# by# centrifugation# in# regular# intervals# and# the# accurate# protein#
concentration# was# determined.# Even# though,# all# efforts# were# made# to# keep# the#





To# support# the# results# presented# in# this# study,# all# ligand# measurements# should# be#
repeated# several# times# to# obtain# publishable# data.# For# any# repeat#measurements,# a#
different#machine#for#example#a#photon#counter#with#constant#stirring#and#controlled#
temperature#should#be#used.#Using#a#more#sensitive#machine#would#also#allow#to#use#
lower# concentrations# of# protein.# In# some# cases# it# can# happen# that# the# protein#
concentration# if# too# high# has# a# decreasing# impact# on# the# fluorescence# (Bisswanger#
2008).# Therefore,# it#might#be# interesting# to# repeat# the#measurements#with#different#
protein#concentrations#for#example#starting#at#0.2#μM#and#then#gradually#going#up#to#2#
μM.# Then# it#would# be#possible# to# see#whether# the#Kd# stays# the# same# for# all# protein#
concentration#or#whether#it#is#affected#by#it.#Providing#constant#stirring#and#controlled#




















crystal# structure# of# DprE1# with# the# ligands# C12# and# RKH06# suggested# a# separate#
binding#site# for#RKH06#away# from#the#FAD#coIfactor.#However,# looking#at# the#results#
from# the# competition# experiment# with# wild# type# DprE1# and# the# single# ligand#
measurements# with# mutant# E294A# and# Y297A,# it# has# been# determined# that# the#
crystallographic# evidence# does# not# represent# the# physiological# binding# behaviour# of#
DprE1.#In#fact,#the#results#suggest#that#RKH06#and#C12#compete#for#a#site#when#titrated#
together# and# therefore# bind# in# the# same# site.# This# was# supported# by# the# mutant#



















For# the# Terrific# Broth,# 12# g# tryptone,# 24# g# yeast# extract# and# 4# ml# glycerol# were#
dissolved# in# 800# ml# diH2O.# This# was# adjusted# to# a# final# volume# of# 900# ml.# For# the#
Terrific# Broth# salt,# 136.09# g# (0.17# M)# KH2PO4# and# 62.7# g# (0.72# M)# K2HPO4# were#
dissolved#in#400#ml#diH2O.#This#was#adjusted#to#a#final#volume#of#500#ml.#
#










For# 100#mg/ml# ampicillin# and# spectinomycin# stocks# and# for# a# 25# mg/ml# kanamycin#




















































1# X# working# solution,# 250# μl# of# 4# X# stock# was# mixed# with# 50# μl# (500# mM)# βI
mercaptoethanol# and# 700# μl# diH2O.# These# working# solutions# were# stored# at# 4°C.# In#











Gel# buffer# (I)# was# prepared# by# dissolving# 118.2# g# Tris# in# 400#ml# diH2O.# The# pH#was#




Gel# buffer# (II)# was# prepared# by# dissolving# 78.8# g# Tris# in# 400#ml# diH2O.# The# pH# was#
















atgttgagcgtgggagctaccactaccgccacccggctgaccgggtggggccgcacagcg   
M  L  S  V  G  A  T  T  T  A  T  R  L  T  G  W  G  R  T  A  
ccgtcggtggcgaatgtgcttcgcaccccagatgccgagatgatcgtcaaggcggtggct   
P  S  V  A  N  V  L  R  T  P  D  A  E  M  I  V  K  A  V  A  
cgggtcgccgagtcggggggcggccggggtgctatcgcgcgcgggctgggccgctcctat   
R  V  A  E  S  G  G  G  R  G  A  I  A  R  G  L  G  R  S  Y   
ggggacaacgcccaaaacggcggtgggttggtgatcgacatgacgccgctgaacactatc   
G  D  N  A  Q  N  G  G  G  L  V  I  D  M  T  P  L  N  T  I   
cactccattgacgccgacaccaagctggtcgacatcgacgccggggtcaacctcgaccaa   
H  S  I  D  A  D  T  K  L  V  D  I  D  A  G  V  N  L  D  Q  
ctgatgaaagccgccctgccgttcgggctgtgggtcccggtgctgccgggaacccggcag   
L  M  K  A  A  L  P  F  G  L  W  V  P  V  L  P  G  T  R  Q  
gtcaccgtcggcggggcgatcgcctgcgatatccacggcaagaaccatcacagcgctggc   
V  T  V  G  G  A  I  A  C  D  I  H  G  K  N  H  H  S  A  G  
agcttcggtaaccacgtgcgcagcatggacctgctgaccgccgacggcgagatccgtcat   
S  F  G  N  H  V  R  S  M  D  L  L  T  A  D  G  E  I  R  H  
ctcactccgaccggcgaggacgccgaactgttctgggccaccgtcgggggcaacggtctc   
L  T  P  T  G  E  D  A  E  L  F  W  A  T  V  G  G  N  G  L  
accggcatcatcatgcgggccaccatcgagatgacgcccacttcgacggcgtacttcatc   
T  G  I  I  M  R  A  T  I  E  M  T  P  T  S  T  A  Y  F  I  
gccgacggcgacgtcaccgccagcctcgacgagaccatcgccctgcacagcgacggcagc   
A  D  G  D  V  T  A  S  L  D  E  T  I  A  L  H  S  D  G  S  
gaagcgcgctacacctattccagtgcctggttcgacgcgatcagcgctcccccgaagctg   
E  A  R  Y  T  Y  S  S  A  W  F  D  A  I  S  A  P  P  K  L  
ggccgcgcggcggtatcgcgtggccgcctggccaccgtcgagcaattgcctgcgaaactg   
G  R  A  A  V  S  R  G  R  L  A  T  V  E  Q  L  P  A  K  L  
cggagcgaacctttgaaattcgatgcgccacagctacttacgttgcccgacgtgtttccc   
R  S  E  P  L  K  F  D  A  P  Q  L  L  T  L  P  D  V  F  P  
aacgggctggccaacaaatataccttcggcccgatcggcgaactgtggtaccgcaaatcc   
N  G  L  A  N  K  Y  T  F  G  P  I  G  E  L  W  Y  R  K  S  
ggcacctatcgcggcaaggtccagaacctcacgcagttctaccatccgctggacatgttc   
G  T  Y  R  G  K  V  Q  N  L  T  Q  F  Y  H  P  L  D  M  F  
ggcgaatggaaccgcgcctacggcccagcgggcttcctgcaatatcagttcgtgatcccc   
G  E  W  N  R  A  Y  G  P  A  G  F  L  Q  Y  Q  F  V  I  P  
acagaggcggttgatgagttcaagaagatcatcggcgttattcaagcctcgggtcactac   
T  E  A  V  D  E  F  K  K  I  I  G  V  I  Q  A  S  G  H  Y  
tcgtttctcaacgtgttcaagctgttcggcccccgcaaccaggcgccgctcagcttcccc   
S  F  L  N  V  F  K  L  F  G  P  R  N  Q  A  P  L  S  F  P  
atcccgggctggaacatctgcgtcgacttccccatcaaggacgggctggggaagttcgtc   
I  P  G  W  N  I  C  V  D  F  P  I  K  D  G  L  G  K  F  V  
agcgaactcgaccgccgggtactggaattcggcggccggctctacaccgccaaagactcc   
S  E  L  D  R  R  V  L  E  F  G  G  R  L  Y  T  A  K  D  S  
cgtaccaccgccgaaacctttcatgccatgtatccgcgcgtcgacgaatggatctccgtg   
R  T  T  A  E  T  F  H  A  M  Y  P  R  V  D  E  W  I  S  V  
cgccgcaaggtcgatccgctgcgcgtattcgcctccgacatggcccgacgcttggagctg   
R  R  K  V  D  P  L  R  V  F  A  S  D  M  A  R  R  L  E  L   
ctgtag   













and# pTrcI60.2IGroES# grown# in# LB# medium# were# unsuccessful.# Besides# fresh#
transformations,#different#glycerol#stocks#were#tried.#Also,#final#IPTG#concentrations#of#
0.2#mM,#0.3#mM#and#0.5#mM#were#tested#to# increase#expression.#The#problem#was,#
that#even# though# the#protein#was#expressed,# it#was#always# insoluble#and#was#nearly#
completely#lost#after#spinning#down#the#crude#lysate.#
#
Fig.' 26:' CoomassiePstained' SDSPPAGE' gel' showing' samples' of' clear' and' crude' lysates' from'
three'different'glycerol'stocks'and'a'sample'of'cells'after'induction'with'IPTG'(+)'as'reference.'
#
As# shown# in# figure# 26,# all# three# glycerol# stocks# produced# a# reasonable# amount# of#






Transformations# with# Rv3790IpCDF# and# pTrcI60.2IGroES# grown# in# LB# medium#
produced# small# amounts# of# soluble# but# defective# protein.# After# the# two# purification#
steps#the#fractions#containing#protein#showed#no#characteristic#yellow#coloration.#This#
indicates# that# the#protein#had#not# taken#up#or# lost# the# FAD# coIfactor# at# some#point#
during#the#process.#Nevertheless,#the#protein#was#concentrated#to#0.9#mg/ml#but#still#
no#coloration#could#be#seen.#A#sample#of#the#concentrated#protein#was#run#on#an#SDSI
PAGE# gel# together# with# concentrated# DprE1# to# check# whether# the# solution# actually#
contained#DprE1.#
#
Fig.' 27:' CoomassiePstained' SDSPPAGE'gel' showing' a' sample' of' the' concentrated' protein' and'
concentrated'DprE1.'
 
Figure# 27# shows# that# both# bands# are# on# the# same# level,# which# means# that# the#
concentrated#protein#was#actually#DprE1.#However,#the#loss#of#the#FAD#coIfactor#could#





































was# gradually# added# from# 0.5# μM# up# to# a# concentration# of# 280.5# μM.# Two#
independent#measurements#were#taken#when#the#protein#was#eight#days#old.#Figure#
29# (bottom)# shows# the#DprE1# saturation# curves#with#327;4.# The# curves#describe# the#
















One# problem#with# this# ligand#was# that# it# needed# to# be# titrated# to# a# very# high# final#
concentration#of#280.5#μM#to# reach#saturation.#However,# the#control#measurements#
with#DMSO#and#buffer#showed#that#after#a#ligand#concentration#of#68.5#μM#the#effect#
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There# is# overwhelming# evidence# from# epidemiological,# cellular# and# animal# studies#
associating#high#iron#levels#with#the#development#of#colorectal#cancer.#Recent#studies#
have# specifically# linked# excess,# unabsorbed# dietary# iron# in# the# colonic# lumen# with#
colorectal#carcinogenesis#and#a#therapy#based#on#the#chelation#of#this#pool#of#iron#was#
suggested.# A# range# of# naturally# occurring,# non;absorbable# and# non;fermentable#
biopolymers,#namely#alginates,#were#identified#as# ideal#candidates#to#study#their# iron#
chelating#properties.#However,#previous#cellular#data# in# the#group# indicated# that# the#
alginate#Manucol#DH#augmented#total#cellular# iron# levels#within#an# in'vitro# setting,#a#
confounding# and# somewhat# surprising# effect# of# a# supposed# iron# chelator.# What#
remains#unknown#is#whether#alginate;bound#iron#within#cells#is#inert#or#whether#it#can#
exert# phenotypical# changes# similar# to# iron# alone.# Therefore,# this# study# aimed# to#
identify#any#phenotypic#changes#associated#with#iron#delivery#using#iron#only#and#iron#
co;incubated#with#Manucol# DH# at# equal# total# cellular# iron# concentrations.# Following#
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and# second# in# women# with# an# estimated# 1.2# million# cases# in# 2008.# Furthermore,#
colorectal#cancer#accounted#for#eight#per#cent#of#all#cancer#deaths# in#the#same#year,#
with#about#608,700#victims#(American#Cancer#Society#2011b).#In#the#UK,#being#ranked#





of# time.# Further# symptoms# include#weight# loss,# abdominal# discomfort# and# cramping#
pains,# tiredness# and# breathlessness# due# to# anaemia# (Cancer# Research#UK,# American#
Cancer#Society#2011a).#
#
As#part#of# the#NHS#bowel#cancer# screening#programme,#a#guaiac;based# faecal#occult#
blood#test#has#been#introduced#to#detect#early#stage#occurrences#of#colorectal#cancer.#
If#any#abnormalities#are#found#in#the#stool#sample,#a#thorough#exam#of#the#bowel#by#






used# for# appropriate# cancer# staging# (Cancer# Research# UK,# American# Cancer# Society#
2011a).#
1.1.2#TNM#staging#










the# intestinal# inner# lining,# through# to# T4#where# the# tumour# has# broken# through# the#















around# 90%# whereas# patients# with# later# stage# tumours# have# a# greatly# decreased#
chance#of#survival#(Gunderson#et'al.#2010,#American#Cancer#Society#2011b).#
1.1.3#Development#
Colorectal# cancer# development# follows# a# stepwise#progression# through# the# so;called#
‘mucosa;adenoma;carcinoma’# pathway# caused# by# an# accumulation# of# mutations# in#













kinases# leading# to#ubiquitination#and#subsequent#degradation#by# the#proteasome.# In#
the# nucleus,# the# transcription# of# Wnt# target# genes# is# repressed# by# the# binding# of#
Groucho#to#T#cell#factor#(TCF)#(Bienz#&#Clevers#2000).#
#
When#Wnt# ligand# binds# to# Frizzled,# a# family# of#Wnt# transmembrane# receptors,# and#
coreceptor#LRP;5/6,# the#cytoplasmic#protein#Dishevelled#(Dsh)#causes#Axin#to#bind#to#
the#Frizzled/LRP#complex# leading# to# inhibition#of# the#protein.#The# inactivation#of# the#
Axin/GSK3β/CK1α/APC#multi;protein#destruction#complex# leads#to#the#stabilisation#of#
β;catenin,#allowing#it#to#translocate#into#the#nucleus.#Here,#β;catenin#replaces#Groucho#
and# binds# to# TCF,# activating# the# transcription# of#Wnt# target# genes# (Bienz# &# Clevers#
2000).#
#
APC# acts# as# negative# regulator# of# the#Wnt# signalling# pathway# due# to# its# role# in# the#
destabilisation# of# free# β;catenin.# In# colorectal# cancer,# the# mutation# and# therefore#
inactivation# of# the# APC# gene# leads# to# an# accumulation# of# β;catenin# within# the# cell#









The# loss# of# APC# occurs# in# the# early# stages# of# colorectal# cancer# and# leads# to# the#
development# of# adenomas.# Due# to# genomic# instability# following# the# formation# of#
adenomas,#subsequent#mutations# in#protooncogenes#such#as#k;ras#and#other#tumour#
suppressor# genes# such# as# TP53# and# TGF;β# lead# to# upregulated# cell# proliferation# and#
downregulated# apoptosis,# giving# the#mutated# cells# a# growth# advantage.# This# causes#
the#cancer#to#progress#from#the#adenoma#to#the#carcinoma#stage#and#can#lead#to#the#






The# American# Cancer# Society# distinguishes# between# two# groups# of# risk# factors#
associated# with# the# development# of# colorectal# cancer,# non;modifiable# (NM)# and#
modifiable#risks.#The#greatest#NM#risk#factor#is#age,#with#85%#of#cases#being#diagnosed#
in# individuals# aged# 60# or# over.# Further# NM# risk# factors# include# a# personal# or# family#
history# of# colorectal# cancer,# diabetes,# chronic# inflammatory# bowel# diseases# such# as#
Crohn’s# disease# and# ulcerative# colitis,# as# well# as# two# know# genetic# predispositions#
called# familial# adenomatous# polyposis# (FAP)# and# hereditary# non# polyposis# colorectal#
cancer# (HNPCC# or# Lynch# syndrome),# accounting# for# around# five# per# cent# of# cases.#
Modifiable# or# lifestyle# related# risk# factors# include# lack# of# physical# activity,# obesity,#




and# spread#and#also#on# the# individual’s# general#health#and#age.# In#most# cases,# early#
stage#cancers#can#be#surgically#removed#without#the#need#for#adjuvant#therapy.#Later#
stage# tumours,# especially# in# the# case# of#metastasis,# often# require# extensive# surgery#
followed#by#a# combination#of# chemotherapy,# radiation#and# /#or#biologically# targeted#
therapies# such#as#monoclonal# antibodies.# The#most# commonly#used# chemotherapies#















Studies#directly# link# these#high# cancer# rates# to# the#Western#diet#which# is# rich# in# red#
meat#and#processed#foods.#Several#reviews#have#reported#that#a#daily#increase#in#red#
meat#consumption#by#100#g#leads#to#a#17%#higher#risk#of#developing#colorectal#cancer#
(Larsson#&#Wolk# 2006).# Based# on# this# observation,# a# range# of# causative# hypotheses#
have#been#suggested#explaining#the#negative#impact#of#red#meat#on#colonic#health.#
#
When# cooking#meat# at# high# temperatures,# heat;induced#mutagens# and# carcinogens#
namely# heterocyclic# amines# and# polycyclic# aromatic# hydrocarbons# are# released.#
Together#with#the#consumption#of#carcinogenic#N;nitroso#compounds#from#preserving#
agents# found# in# processed# red#meat,# they# are# thought# to# be# linked# to# colon# cancer#















Furthermore,# it#has#been#suggested#that# the#high#fat#content#of#meat#could# increase#
the# production# of# secondary# bile# acids# which# can# have# negative# effects# on# colonic#









A# meta;analysis# of# several# cohort# studies# looking# into# the# effects# of# haem# iron# on#
colonic# health# published# in# 2011,# looked# at# the# data# from# over# 500,000# individuals.#
They#found#a#significant#and#consistent#correlation#between#the#amount#of#red#meat#
consumed# and# the# risk# of# developing# colorectal# cancer,# with# people# in# the# high#
consume# category# being# 95%# more# at# risk# than# those# in# the# low# consume# group#
(Bastide#et'al.#2011).#Also,#a#beneficial#effect#was#associated#with#the#regular#consume#
of# calcium#which# has# been# found# to# greatly# decrease# iron# absorption# from# the# diet#
(Hallberg# et' al.# 1992,# Corpet# 2011,# Jemal# et' al.# 2011).# This# study’s# results# are#
supported#by#the#findings#of#the#European#Prospective#Investigations#into#Cancer#and#





They# further# found#an#association#between#dietary# fibre# intake# from#vegetables# and#
fruit# in# the#prevention#of# colon#cancer#and# there#are# two#hypotheses#as# to#why# this#
might#be.#Firstly,#fibre#increases#stool#weight,#reduces#transit#time#and#dilutes#colonic#
contents# reducing# their# contact# with# the# intestinal# lining.# Stimulation# of# bacterial#
anaerobic#fermentation#leads#to#the#production#of#butyrate#which#has#been#found#to#
limit#cell#proliferation#and#induce#apoptosis#in#cancer#cell# lines#(Bingham#et'al.#2003).#





Besides# studies# linking# iron# from# the# diet# to# the# worldwide# incidence# of# colorectal#
cancer,# others# have# found# a# connection# between# increased# body# iron# stores# and#
cancer.# A# meta;analysis# carried# out# by# Nelson# in# 2001# combined# the# data# from# 33#
epidemiological#studies#out#of#which#75%#supported#this#association.#
#
Knekt# et' al.# (1994)# used# transferrin# saturation# as# a# means# to# determine# body# iron#
stores.# They# found#a# significant# increase# in# colorectal# cancer# incidence# in# individuals#
with# a# transferrin# saturation# greater# than# 60%.# Moreover,# several# studies# reported#
that#individuals#who#regularly#lowered#their#body#iron#stores#through#blood#donation#










Hereditary# haemochromatosis# has# been# reported# to# be# a# major# risk# factor# in# the#
development#of#colorectal#cancer#(Chua#et'al.#2010).#Patients#with#this#genetic#disease#





and# iron# becomes# evident.# A# study# by# Kato# et' al.# (1999)# did# not# find# supporting#
evidence# associating# increased# body# iron# stores# to# colorectal# cancer# development.#
They#did,#however,#suggest#a#link#between#excessive#luminal#iron#concentration#and#an#




progression# and# cell# growth.# Given# their# accelerated# proliferation# in# comparison# to#







al.# (2006)# reported# increased# iron# staining# in# colorectal# carcinomas# compared# to#
normal#colonic#epithelium#(see#figure#33).#
#
Fig.' 33:' Perl’s' Prussian' blue' staining' used' to' examine' colonocyte' iron' content:' (A+B)' Colonic'




cellular# iron# import,# namely# duodenal# cytochrome# b# (DCYTB),# divalent# metal#
transporter#1#(DMT1)#and#transferrin#receptor#1#(TfR1),#and#a#reduction#in#production#
of# the# iron# export# proteins# hephaestin# and# ferroportin.# Loss# of# the# latter# was#






Studying# the# effects# of# physiological# ferric# or# ferrous# iron# on# human# colon#
adenocarcinoma#HT29#clone#19A#cells,#Glei#et'al.#(2009)#found#that#after#treating#cells#
with#ferric;nitrilotriacetate#or#haemoglobin,#an#increased#iron#uptake#causing#oxidative#
DNA# damage# in# the# cells# could# be# observed.# Furthermore,# the# use# of# quercetin,# a#
plant;derived# flavonoid# antioxidant,# inhibited# the# DNA# damage# and# they# therefore#
linked#increased#iron#levels#in#the#colon#to#colorectal#carcinogenesis.#
#




iron,# it# lead# to# increased#Wnt# signalling#while# the#wild;type# APC# cell# lines#were# not#
affected#by#elevated#iron#levels#(Brookes#et'al.#2008).#
1.2.3#In#vivo#studies#–#Animal#models#
There# is# a# vast# amount# of# evidence# from# animal# studies# indicating# an# association#
between# iron#and# tumour# formation.#Richmond# (1959),#as#one#of# the#earliest,# found#
that# intramuscular# injection# with# iron;dextran# lead# to# sarcoma# formation# at# the#
administration# site# in# 70%# of# rats.#More# recent# studies# have# tried# to# link# increased#
intake# of# dietary# iron# to# colorectal# carcinogenesis.# Pierre#et' al.# (2003)# looked# at# the#












cell# growth# in# the#colonic# crypts#which# links# iron# to# the# formation#of# tumours# in# the#
colon.# Furthermore,# rats# fed# with# dietary# haem# presented# with# augmented# colonic#





that# while# increased# dietary# iron# levels# lead# to# an# increase# in# tumour# formation,#
augmented#systemic#iron#levels#did#not#cause#this#effect.#These#findings#are#supported#
by#a# recent# study,#which#explicitly# links# the# luminal# rather# than# the# systemic#pool#of#
iron#to#colorectal#carcinogenesis.#It#showed#a#significant#decrease#in#tumour#burden#in#
a#mouse#model#of#intestinal#tumourigenesis#(Apcmin/+)#when#fed#an#iron#deficient#diet#
compared# to# a# control# group.# A# third# group# of# mice# was# fed# an# iron# deficient# diet#
whilst# being# systemically# replenished# using# iron# dextran.# Again,# tumour# burden#was#










Looking# at# the# data# presented# previously,# a# relationship# between# colorectal# cancer#
incidence# and# excess# luminal# iron# is# undeniable.# However,# the# question# arises# as# to#
how#iron#can#be#toxic#to#the#human#body.#
#
Iron# is# vital# for# all# organisms,# as# it# plays# a# crucial# role# in# the# active# side# of# many#
proteins# involved# in# a# range# of# metabolic# processes# such# as# oxygen# transport# via#
haemoglobin,#DNA#synthesis,#cell#cycle#progression#and#growth#(Heli#et'al.#2011,#Torti#
&# Torti# 2013).# Examples# of# such# proteins# are# cytochromes,# Fe;S# centre;containing#
proteins,# lipoxygenases,# cyclooxygenases,# and# ribonucleotide# reductase# (Richardson#
2002).#Iron#homeostasis# is#tightly#regulated#via#intestinal#absorption#and#most#iron#in#











demonstrates# the# formation# of# ROS# from# molecular# oxygen# in# the# presence# of# a#
transition#metal#such#as#iron.#
#
Free# radical# formation# results# in# lipid,# protein# and# DNA# damage# causing#
carcinogenesis;inducing#mutations#(Heli#et'al.#2011).#Further,#oxidative#stress#can#lead#
to#necrotic#cell#death#rather#than#regulated#apoptosis#causing#neighbouring#cells#to#be#
affected# (Halliwell# 2011).# Finally,# ROS# can# also# damage# or# affect# signalling# pathways#
leading# to# modulated# cell# growth# and# tumour# promotion# and# the# activation# of#
protooncogenes#such#as#c;FOS,#c;JUN#and#c;myc#(Hussain#et'al.#2003).#
#
Fig.'34:'Redox' reactions' showing' the' formation'of'ROS:' (1)' Superoxide' radical' formation;' (2)'
Peroxide' ion' formation' (3)' Hydrogen' peroxide' formation;' (4)' Hydroxyl' radical' formation' via'
FentonNtype'reaction'of'ferrous'iron'with'hydrogen'peroxide;'(5)'Reduction'of'ferric'iron'by'the'







Based#on# the#detrimental#effects#of#unbound# iron# in# carcinogenesis,# in# recent# years,#




The# first# candidate# considered# as# an# iron# chelator# in# cancer# therapy# was#
Desferrioxamine,# a# compound# currently# used# in# the# treatment# of# iron# overload#
diseases# such# as# haemochromatosis# and# β;thalassemia.# Several# in' vitro,# in' vivo,# and#
clinical#trial#studies#have#found#that#Desferrioxamine#has#anti;neoplastic#effects#against#
both#bone# cancer# and#neuroblastoma.#Due# to# its# limitations,# such#as# the# inability# to#








Orally# active# chelators# that# are# aimed# at# the# removal# of# systemic# iron# have# to# fulfil#
several#criteria.#They#have#to#chelate#nontransferrin;bound#iron,#chelate#iron#from#the#














These# five#criteria#were#chosen# for# the# following#reasons.#A#non;absorbable#chelator#
binds#iron#within#the#colon#rather#than#systemic#iron.#This#is#important,#as#we#do#not#
want#to#elevate#the#risk#of#anaemia#in#patients#with#for#example#ulcerative#colitis#and#
previous# research# has# shown# that# it# is# not# the# systemic# pool# of# iron# causing# colon#
cancer# (Radulescu#et' al.# 2012).# If# the# chelator#was# fermentable,# it# could# get# broken#
down#by#the#intestinal#microbiota,#reducing#its#iron#binding#capacity#and#possibly#even#
releasing#any#bound#iron.#The#chelator#must#be#selective#for#iron#to#avoid#any#removal#
of# essential# or# beneficial# ions# such# as# calcium,# which# has# been# proven# to# have#















several#bacterial# strains# such#as#Azotobacter'vinelandii# and#Pseudomonas'aeruginosa#






difference# between# these# uronic# acids,# however,# this# causes# them# to# arrange# in#
different# chair# conformations# (Gacesa# 1988).# The#M#and#G#monomers# can# either# be#
arranged# as# homopolymeric# blocks# namely# poly(β;D;mannuronate)# or# poly(α;L;















































Because# of# their# gel# forming# properties,# alginates# have# found# a# wide# range# of#
applications#mainly#as#stabilisers,#viscosifiers#and#gelling#agents#in#the#food#and#drinks#
industry# (Gacesa# 1988,# Draget# &# Taylor# 2011).# Alginates# are# further# used# in# the#
pharmaceutical# industry# in# anti;ulcer# and# reflux# medication,# emulsion# stabilisers,#
gastro#enteric#coatings#for#tablets#and#wound#dressings.#Furthermore,#they#are#used#as#






Based# on# previous# research# by# the# Tselepis# group# (unpublished# data)# a# range# of#
alginates#with#different#G/M#ratios#and#block#compositions#was#chosen#to#study#their#
iron# chelation# properties,# namely# Protanal# LFR# 5/60,# Protanal# RF# 6650,#Manucol# LD,#





These# alginates# were# all# stratified# in# terms# of# their# iron# binding# potential# under#
physiological#relevant#conditions.#Based#on#initial#experiments,#Man#DH#was#chosen#as#
















Fig.' 41:' Analysis' of' total' cellular' iron' content' (assessed' using' the' Ferrozine' assay)' in' human'




using# Man# DH# to# increase# the# bioavailability# of# iron# in# human# epithelial# colorectal#
adenocarcinoma# CaCo;2# cells.# They# showed# that# co;incubating# cells# with# 30# μmol/l#







Based# on# the# confounding# and# somewhat# surprising# iron# augmenting# effect# of#Man#
DH,#the#aims#and#objectives#of#this#study#were#determined.#
#




constant# concentration#of# iron# (100#μM)# and# varying# alginate# concentration#until# an#
equal# level# was# reached.# The# total# cellular# iron# content# was# assessed# using# the#




suitable# iron# chelator# than#Man#DH.#Therefore,#MTT#assays#were#performed#with#all#
alginates# to# observe# any# effects# on# cell# viability.#Western# blotting#was# employed# to#











The#chemicals#and#other# ingredients#mentioned# in# this# section#were#purchased# from#
Sigma;Aldrich#Company#Ltd#or#Fisher#Scientific#UK#Ltd#unless#stated#otherwise.#Sterile#
phosphate#buffered# saline# (PBS)#was#purchased# from# the# School# of# Cancer# Sciences.#
The#recipes#for#all#buffers#/#stocks#/#solutions#mentioned#in#this#section#can#be#found#in#
the# appendix.# All# tissue# culture# relevant# procedures# were# carried# out# in# a# sterile#
laminar# flow# hood# which# was# cleaned# with# 70%# industrial# methylated# spirits# (IMS)#
before#and#after#use.#
2.1#Tissue#Culture#
The# human# colorectal# carcinoma# RKO# cell# line#was# used# for# all# in' vitro'experiments#
carried#out#in#this#study.#
2.1.1#Maintaining#cell#cultures#
Adherent#cells#were#routinely#cultured# in# tissue#culture# flasks# in#Dulbecco's#Modified#
Eagle's#Medium#(DMEM)#supplemented#with#10%#fetal#calf#serum#(FCS),#100#units/ml#
penicillin#and#0.1#mg/ml#streptomycin#in#a#37°C#incubator#with#95%#relative#humidity#
and# 5%# CO2.# They# were# split# regularly# whenever# they# reached# between# 80;100%#
confluency# (every# three# to# four# days).# In# a# sterile# hood# the# growth# medium# was#
removed,#the#cells#were#washed#with#10#ml#PBS#to#remove#any#residual#medium#and#
then#5#to#7.5#ml#trypsin#(TrypLE#Express#(1x)#–#gibco#Life#Technologies)#was#added.#The#





The# solution# was# transferred# into# a# 15#ml# tube# and# centrifuged# for# five#minutes# at#
1500#RPM#to#pellet# the#cells.#The#supernatant#was#decanted#and#the#pellet#was# fully#





1# x# 105# cells/ml.# Therefore,# the# cells# were# pelleted# and# resuspended# in# 10# ml# 10%#
DMEM# as# explained# above# and# then# the# cell# density# was# determined# using# a#









Once# established,# the# growth#medium#was# removed# and# a# stimulation#medium#was#
added# to# the# cells.# For# an# alginate;loaded# medium,# the# required# amount# of# 10%#
DMEM# was# mixed# with# the# appropriate# amount# of# 2%# alginate# stock.# For# an# iron;
loaded#medium,#the#required#amount#of#10%#DMEM#was#mixed#with#the#appropriate#
amount# of# 10# mM# iron# (Fe)# and# 1# mM# sodium# L;ascorbate# (Na;asc)# stock.# For# an#
alginate;Fe#loaded#medium,#appropriate#amounts#of#2%#alginate#stock#and#10#mM#Fe#1#
mM#Na;asc#stock#were#pre;mixed#before#adding#the#required#amount#of#10%#DMEM.#
The# maximum# alginate# concentration# used# was# 0.3%# and# a# standard# final#
concentration#of#100#μM#Fe#was#used#for#all#experiments.#Cells#were# incubated#with#
















































standard# calibration,# following# standards# were# used:# water# (used# to# make# up#
standards),#0#mM#(90#μl#HEPES#lysis#buffer,#200#μl#20%#trichloroacetic#acid#(TCA),#600#
μl# ferrozine),#0.05,#0.1,#0.2,#0.3#and#0.5#mM#(200#μl#standard#stock,#200#μl#20%#TCA,#



























90#μl#determined# in# the#protein#assay.#Finally,#an#overall#mean# for#each#condition# in#
nM,# the# standard# deviation# and# standard# error# were# determined# and# the# data# was#













sufficient# mixing# and# the# assay# was# left# to# incubate# at# 37°C# for# 3# 1/2# hours.# The#
medium#was#mostly#removed#with#a#stripette#and#any#residual#medium#was#removed#
with# a# P1000# pipette.# To# release# the# dye# from# the# cells,# 2# ml# dimethyl# sulfoxide#
(DMSO)#was#added#to#each#well#and#the#cells#were#scraped# into#solution#using#a#cell#
scarper.# Then,# 200#μl# of# each# sample#was# transferred# into# a# 96#well# plate.# This#was#
done# in# triplicate# for# each# sample# as# shown# in# figure# 42.# The# absorbance#was# read#
immediately# at# λ=550# nm# with# a# plate# reader# (Victor
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for# all# triplicate# readings# and# the# overall# mean# for# each# condition# were# calculated.#


















Using# the# Mini;PROTEAN# Tetra# handcast# system# (BIO;RAD),# SDS;PAGE# gels# were#
prepared#fresh.#To#cast#a#gel,#all#bottom#gel#ingredients#were#mixed#according#to#table#
16#and#poured#between#the#glass#plates.#To#achieve#an#even#surface,#isopropanol#was#




gel.# Immediately,# a# clean# 10#well#Mini;PROTEAN# comb#was# pressed# into# the# top# gel#






Scientific)# was# added# to# the# first# well.# The# amount# calculated# for# 20# μg/μl# protein#













For# protein# transfer,# a# Hybond# hydrophobic# polyvinylidene# difluoride# (PVDF)#


































mixed# in# a#1:1# ratio# and# kept#protected# from# light#until# use.# The#paired#membranes#
together#with# 5#ml# detection# reagent#were# sealed# in# a# plastic# bag# and# the# reagents#
were# gently# rubbed#over# the# sealed#membranes# for# one#minute.# The#bags#were# cut#
open# and# the# reagents# were# drained# before# placing# the# membranes# in# a# clean#
developing# cassette# (Amersham# Hypercassette# –# GE# Healthcare).# In# a# dark# room,# a#
developing# film# (Amersham# Hyperfilm# MP# –# GE# Healthcare)# was# placed# on# the#














A# dialysis# tubing# cellulose# membrane# from# Sigma;Aldrich# with# a# typical# molecular#
weight# cut;off# around# 14,000# (average# flat# width# 33mm)# was# used# for# these#
experiments.#It#was#cut#into#strips#with#the#appropriate#length#to#hold#10#ml#of#sample.#
To# remove#contaminants,# the#membrane#strips#were#washed# in#700#ml#diH2O# for#30#






The# bags#were# placed# in# individual# beakers# (three# bags# per# alginate# /# beaker)# filled#


















shake#plate.# The#bags#were#also# stirred#every#20#minutes# to#ensure# that# all# samples#
were#evenly#exposed#to#the#medium.#After#the#incubation#period,#the#bags#were#rinsed#
twice#with#100#ml#diH2O.#A#1#ml# sample# (prewash)#was# taken# from#each#bag#before#
washing# them# in#400#ml#diH2O# for#1.5#hours#at#37°C#on#a# shake#plate.#Another#1#ml#
sample#(washed)#was#taking#after#the#washing#period.#
2.6.4#Ferrozine#Assay#
The#Ferrozine#assay#was#used#to#assess# the# iron#content# in# the#prewash#and#washed#
samples.# Therefore,# 200#μl#of# each#alginate# sample#was#mixed#with#600#μl# ferrozine#
stock.# Calibration# standards# were# also# prepared# (see# 2.3.1).# Then,# 200# μl# of# each#
sample#was#transferred#into#a#96#well#plate.#This#was#done#in#triplicate#for#each#sample#
as# shown# in# figure# 42.# The# absorbance# was# read# at# λ=550# nm# with# a# plate# reader#







The# PSA# assay# was# carried# out# in# order# to# accurately# determine# the# carbohydrate#
(alginate)# content# in# the# SLS# /# DLS# samples.# The# assay#was# optimised# based# on# the#
original#protocol#by#Dubois#et'al.#(1956).#
#
For# a# standard# calibration,# following# standards# were# used:# SLS# /# DLS# water,# 0.015,#





acid#was# added# rapidly# as# a# constant# stream# against# the# liquid# surface# using# a# 5#ml#
pipette.# For# reliable# results# this# process# needed# to# be# performed# identically# for# all#
samples.# For# this# reason,# one# measurement# for# each# standard# and# duplicate#
measurements# for# all# alginate# samples#were# carried# out# to#minimise# any# error.# The#
solutions#were#allowed#to#stand#to#cool#down#for#10#minutes,#then#shaken#vigorously#
and# subsequently# incubated# in# a# waterbath# at# 37°C# for# 20# minutes.# To# read# the#
absorbance,#200#μl#of#each#sample#was#transferred#into#a#96#well#plate.#This#was#done#
in#triplicate#for#each#sample#as#shown#in#figure#42.#The#absorbance#was#read#at#λ=490#
nm#with# a#plate# reader# (Victor2# 1420#Multilabel# Counter# –#Wallac).#Using# the# values#
obtained#for#the#standards,#the#carbohydrate#content#for#each#sample#was#calculated#






To# determine# the# size# and# molecular# weight# (MW)# of# each# alginate,# DLS# and# SLS#
measurements# were# recorded# on# a# Malvern# Zetasizer# Nano# ZS# using# a# 1# cm# path#
length,#quartz#cuvette.#The#measurements#were#carried#out#on#the#prepared#SLS#/DLS#







































cuvette# was# thoroughly# cleaned# by# rinsing# with# diH2O# and# then# with# acetone.# Any#
residual# liquid#was# removed#with# a# filter# tip# pipette# and# the# cuvette#was# left# to# dry#
before#adding#the#next#sample.#
#








carried# out# using#Microsoft# Excel# for#Mac# 2011.# Differences# were# considered# to# be#
significant# at# p# ≤# 0.05.# (*)# Denotes# statistical# significance# compared# to# control,# p# ≤#
0.05.#(+)#Denotes#statistical#significance#compared#to#Fe#100#μM#only#value,#p#≤#0.05.#
Error#bars#represent#±#SEM.#Each#figure#represents#data#from#one#experiment#unless#








Previous# experiments# in# the# Tselepis# group,# found# that# Man# DH# had# an# iron#
augmenting# rather# than#a#chelating#effect#on# in'vitro.#Therefore,# the# first#aim#of# this#
study#was#to#assess#whether#the#type#of#iron#delivery#using#Fe#only#or#Fe#with#Man#DH#
had# any# effect# on# cell# phenotype.# In# order# to# do# this,# equal# total# cellular# iron#
concentrations#had# to#be# achieved#when# incubating# cells#with#both# conditions.# Cells#
were# stimulated# with# a# constant# concentration# of# 100# μM# Fe# and# varying#Man# DH#






shown# in# figure#44# (a),#whilst#a#Man#DH#concentration#of#0.09%# (p#=#0.004)#was# too#
low,#there#was#no#statistical#difference#between#Fe#only#and#Fe#with#Man#DH#at#0.1%#
and# 0.2%.# However,# an# equal# iron# level# did# not# appear# to# be# reached# at# these#
concentrations.# Due# to# the# difference# between# Fe# only# and# Fe# with# Man# DH# 0.1%#




0.15%.# As# shown# in# figure# 44# (b),# Fe# with#Man# DH# 0.14%# (p# =# 0.168)# was# the# only#
condition#that#was#statistically#not#different#to#Fe#only,#meaning#that#equal#cellular#iron#







Fig.' 44:' Total' cellular' iron' levels' as' determined' using' the' Ferrozine' assay' for' RKO' cells'
stimulated'with'Fe'only'and'(a)'Fe'with'Man'DH'at'0.09%,'0.1%'and'0.2%;'(b)'Fe'with'Man'DH'
at'0.12%,'0.13%,'0.14%'and'0.15%.'(*)'Denotes'statistical'significance'compared'to'control,'p'≤'












DH#with#and#without# Fe# to#both,# control#or# Fe#only.# Furthermore,# Fe#only# increased#
viability#by#around#12%,#but#this#effect#was#not#statistical#compared#to#control.#
#







Based#on# the#observations#made# in# the#experiments#using#Man#DH#only,# the# second#
aim# of# this# study#was# to# look# at# the#whole# range# of# alginates# to# possibly# identify# a#













DH# (14%)# and# LFR# (17%)# significantly# decreased# cell# viability# relative# to# the# control.#
This#decrease#was#also#significant#compared#to#Fe#only.#
#















Fig.'47:'Cellular'viability'as'determined'using' the'MTT'assay' for'RKO'cells' stimulated'with'Fe'








To# assess# the# effect# of# alginates# in# combination#with# Fe,# RKO# cells#were# stimulated#
with#Fe#only#and#all#alginates#at#0.3%#with#Fe.#As#shown#in#figure#48#(a)#and#(b),#there#
was#great#variation#in#ferritin#expression#over#the#range#of#alginates#and#Man#LD#was#








Fig.' 48:' Cellular' ferritin' expression' as' assessed' by'Western' blotting' for' RKO' cells' stimulated'
with'Fe'only'and'all'alginates'at'0.3%'with'Fe.'(a)'Western'blot'showing'bands'for'βNactin'and'
ferritin' expression;' (b)' Graph' showing' ferritin' expression' normalised' by' βNactin.' (*)' Denotes'














Fig.' 49:' Cellular' ferritin' expression' as' assessed' by'Western' blotting' for' RKO' cells' stimulated'
with'Fe'only'and'Man'LD'0.14%'and'0.3%'with'Fe.'(a)'Western'blot'showing'bands'for'βNactin'







In#order# to#assess# the#alginates’# iron# loading#capacity,# the#alginates#were#dialysed# in#
different# Fe# containing#media.# The# Ferrozine# assay#was# then# used# to# determine# the#
amount#of#Fe#bound#by#the#alginates#pre;#and#post;wash.##
#
As#shown# in# figure#50# (a;c),#all#alginates#at#0.3%#were# incubated# in#triplicate#with#10#
μM# FeSO4# and# 10# μM# Na;asc# in# diH2O,# colourless# DMEM# and# 10%# FCS# colourless#
DMEM.# To# assess# iron# binding# at# colonic# luminal# iron# concentrations,# in# a# further#














Fig.) 50:) Alginate) iron) loading)
capacity) as) assessed) by)
dialysis) and) Ferrozine) assay.)
Alginates) at) 0.3%) were)
stimulated)with)100)μM)FeSO4)
10) μM) NaOasc) in) different)
dialysis) media:) (a)) diH2O) (b))
colourless) DMEM) (c)) 10%) FCS)
colourless) DMEM;) (d))
Alginates) at) 0.3%) stimulated)
with)200)μM)FeSO4)20)μM)NaO
asc) in) 10%) FCS) colourless)
DMEM.) Dialysis) for) 1) ½) h)
followed) by) 1) ½) h) wash) in)
diH2O;) 37°C) on) a) shake) plate.)






The! in) vitro! studies! showed! that! the! alginates! have! different! effects! on! cell! viability!



















Manucol!DH! 420.9! 16.4! 24.82! 83.6! 0! 0! 1!
Keltone! 717.7! 2.9! 15.58! 97.1! 0! 0! 2!
Manucol!LD! 361.6! 1.0! 10.76! 99.0! 0! 0! 3!
LFR!5/60! 360.4! 0.3! 8.864! 99.7! 0! 0! 4!













Consistent! PSA! assay! results! were! obtained! for! Man! LD,! Man! DH! and! LFR! and!
therefore! SLS! measurements! could! only! be! performed! these! alginates.! The! data!
gathered!from!this!are!presented!in!table!19.!
!








Zetasizer! Nano! ZS.! According! to! the! information! obtained! from! the! machine,! good!
quality!data!was!collected!for!these!measurements.!
!















































iron! binding! capacity! under! physiological! conditions,! it! significantly! augmented! total!
cellular! iron! levels!within!an! in)vitro!setting! in!comparison!to!a! iron!only!control! (see!
figure! 40! and! 41).! This! is! a! confounding! and! somewhat! surprising! effect,! making! it!
unsuitable! as! an! iron! chelator.! However,! what! remained! unknown! was! whether!
alginateLbound!iron!within!cells! is! inert!or!whether! it!can!exert!phenotypical!changes!




In!order! to!carry!out! these!experiments,! first! it!was!necessary! to!achieve!equal! total!
cellular!iron!concentrations!for!both!conditions.!As!shown!in!figure!44!(b),!at!a!Man!DH!




The! question! behind! the! cell! viability! studies! with! Man! DH! was! even! though! the!
measurement! for! total! cellular! iron! suggests! that! there! are! equal! amounts! of! iron!
present! in! the!cells,!what!effect!does! it!have!on!the!cell!phenotype!when!the! iron! is!
delivered!by!an!alginate.!It!was!hypothesised,!that!when!cells!load!the!same!amount!of!








without! Fe,! no! change! was! observed.! Given! that! cancer! cells! have! a! higher!









The! aim! of! this! comparative! viability! experiment!was! to! find! an! alginate! that! could!
decrease!cell!viability,!at!the!same!concentration!at!which!Man!DH!had!no!effect.!The!
data!obtained! from!this!experiment!was!used!more! to! find!an!alginate! that! shows!a!
trend! to! have! the! ability! to! reduce! cell! viability! rather! than! to! make! a! definite!
conclusion! about! the! effect! that! alginates! have! on! cells.! This!was! based! on! the! fact!





Even! though,! thorough! cell! counting! and! accurate! plating! techniques! were! applied,!
there! still! might! have! been! variations! between! wells! and! especially! experiments.!
Another! factor! that! could! have! an! impact! on! the! outcome! of! the!MTT! assay! is! the!














(18%)! and! LFR! (17%)! significantly! decreased! viability! compared! to! control.! In! the!









The! results! presented! in! figure! 47! came! from! four! independent! experiments! and!
provides!sufficient!evidence!to!reinforce!the!previous!finding!(figure!45)!that!Man!DH!
in! fact! has! no! impact! on! cellular! viability! and! further! support! the! data! from! the!




determine! levels! of! ferritin! expression! in! cells.! Ferritin! is! a! highly! conserved! storage!
protein! for! intracellular! iron! and! research! has! found! a! positive! association! between!
ferritin! overexpression! and! increasing! iron! supply! and! import! (Cairo! et) al.! 1985).!
Ferritin!consists!of!two!parts,!the!heavy!and!light!chain!subunits,!which!if!put!together!
form!an! iron!storage!cavity!holding!up! to!4500! iron! (III)! atoms!per! ferritin!molecule.!
While!the!heavy!chain!subunit!catalyses!the!oxidation!of!iron!from!the!ferrous!to!the!






concentration! including! iron! loosely!bound!to!the!cell!surface,! ferritin!expression!can!
be! used! to! measure! only! the! intracellular! iron! content! and! therefore! gives! a! more!




control! proving! the! point! that! with! increased! iron! availability,! ferritin! expression! is!
amplified.! Looking! at! both! figure! 48! and! 49,! it! is! explicit,! that! out! of! the! range! of!
alginates,!Man!LD!was!the!only!one!showing!no!statistical!difference!to!control!but!to!
Fe! only,! which! means! that! Man! LD! significantly! decreased! ferritin! expression! and!
therefore!lowered!cellular!iron!uptake.!
!






concentrations,! dialysis! in! different! ironLloaded!media! was! used.! Both! the! samples’!





When! looking!at! the! results! shown! in! figure!50! (a),! it! is! apparent! that! the!alginates’!
iron!binding!capacity!was!more!than!seven!times!higher!when!dialysed!in!diH2O!than!in!
any!of!the!other!conditions.!Dialysis!in!diH2O!shows!how!much!iron!the!alginates!could!
bind! in! the!absence!of!other!divalent! cations!especially! calcium.! In!both,! the!phenol!
red!liquid!DMEM!used!for!tissue!culture!and!the!colourless!DMEM!powder,!calcium!is!
present! at! a! concentration! of! 0.2! g/l! (SigmaLAldrich),! which! could! have! a! negative!
effect! on! the! alginates’! iron! binding! affinity.! Furthermore,! other! weak! chelators!












all! alginates! in! order! to! link! them! to! their! iron! binding! capacity! in! solution.! In! the!










larger!a!particle,! the!more! light! it! scatters!and! therefore! the!smaller! the!particle! the!







sample! there! are! different! sizes! leading! to! a! nonLuniform! size! distribution! which! is!
represented!in!peaks!on!the!graph.!Each!of!the!alginates!has!two!peaks!except!for!RF!
6650,! which! has! three! peaks! meaning! that! it! is! even! more! polydispersed! than! the!
others.!One!can!see!that!with!increasing!size,!the!peaks!are!shifted!to!the!right!on!the!
graph!indicating!more!particles!with!greater!diameters.!Therefore,!the!alginates!can!be!
divided! into! three!groups:! small! alginates! (RF!6650,! LFR,!Man!LD),!medium!alginates!
(Keltone)!and!large!alginates!(Man!DH).!
!








SLS! data! was! only! gathered! for!Man! LD,!Man! DH! and! LFR.! Due! to! time! constrains,!
inconsistent! results! from!the!PSA!assay!and!poor!quality!data,! it!was!not!possible! to!
obtain!results!for!the!other!alginates.!
!
The!MWs! obtained! for!Man! LD! (47.4! kDa)! and! LFR! (34.3! kDa)! were! based! on! high!
quality! data! and! were! found! to! be! consistent! with! literature.! The! MW! previously!
reported! for!Man!LD!was!around!40!kDa! (FAO!Corporate!Document!Repository)!and!
for!LFR!around!34.7!kDa!(manufacturer’s!information!FMC!BioPolymers).!The!data!for!
Man! DH! (131! kDa)! on! the! other! hand! was! not! consisted! between! different!
measurements.! Nevertheless,! the!MW! values! obtained!were! always! greater! than! of!















machine! and! lead! to! low! quality! data.! Furthermore,! there! can! be! problems! due! to!
contamination!of!the!sample!with!dust!or!other!aggregates!(Strand!et)al.!1982).!Even!if!
the!samples!are!filtered,!when!transferring!them!into!the!machine,!contamination!with!






carbon! atoms,! C4! and! C5,! which! allow! them! to! be! studied! using! CD! spectroscopy.!
Positive!bands!are!associated!with!DLuronic!acids!(M!units)!whereas!polyLG!units!cause!





into! two!distinct!groups,! lowLG!alginates! (Man!LD,!Man!DH!and!Keltone)!and!highLG!





units! in! an! alginate! sample,! CD! cannot! be! used! to! determine! the! M! content! of! a!
sample.! Also,! rather! than! providing! actual! values! for! G! content,! the! information! is!














LFR! had! the! same! in) vitro! effects! as!Man! DH,! low! iron! binding! capacity,! it! was! the!
second!smallest!alginate!with!a!low!MW!of!34.3!kDa!(literature!around!34.7kDa)!and!it!
















not! statistical! decrease! in! ferritin! expression! and! it! was! the! second! largest! alginate!
with!the!third!lowest!G!content.!Ma!et)al.!(2007)!determined!the!G!content!of!Keltone!
to! be! 60%! which! ties! in! with! the! ranking! of! this! alginate! and! the! data! found! in!
literature!found!for!other!alginates.!
!



















as! iron! chelators.! Firstly,! polyLG! units! have! a! high! binding! affinity! for! calcium! and!
preferably!bind!calcium!over!iron!(Gacesa!1988).!It!is!therefore!not!surprising,!that!all!
high! G! alginates! were! found! to! have! no! or! little! effect! on! RKO! cells! and! low! iron!




Secondly,! polyLG! alginates! are! restricted! by! their! buckled! chain! conformation!which!
changes!into!the!soLcalled!“eggLbox”!structure!to!form!microcrystalline!junctions!with!
divalent!cations.! In!comparison!to!that,!high!M!alginates!have!a!ribbonLlike!structure!









The! work! presented! in! this! thesis! provides! preliminary! evidence! for! a! structureL
function! correlation!between! the!alginates’! physiochemical! properties! and! their! iron!
binding!potential.!Nevertheless,!further!testing!is!needed!to!assess!and!validate!these!
findings! in!order! to!obtain!a! list!of! the!most!desirable!criteria! for!an!alginate!as! iron!
chelator.!
!
Man! DH! and! Man! LD! are! extracted! from! the! same! algal! source! which! is! split! into!
different! fractions!during! the!manufacturing!process.!They!both!have! the! same!G/M!
ratio! but!Man!DH! is! the! bigger! fraction!while!Man! LD! is! the! smaller! fraction! of! the!
same!algae!(manufacturer’s!information,!FMC!BioPolymers).!This!has!been!supported!
by!the!data!gathered!in!this!study,!showing!that!Man!DH!and!Man!LD!had!very!similar!
G! content! with! Man! DH! being! the! largest! and! Man! LD! being! the! second! smallest!
alginate! out! of! the! range.! Insightful! future! investigations! to! prove! the!hypothesis! of!
small,! low!G! alginates! being! better! iron! chelators! than! large,! high!G! alginates! could!
include!the!following!experiment.!Man!DH!could!be!digested!into!smaller!fragments!to!
achieve!a!more!similar!size!to!Man!LD.!If!the!hypothesis!is!correct,!then!these!digests!




In! conclusion,! this! study! provides! an! initial! yet! enlightening! investigation! into! the!
chemical,!physical!and!in)vitro!properties!of!the!alginates.!The!data!obtained!indicates!









In! the! following! the! recipes! for! all! buffers! /! stocks! /! solutions! referred! to! in! the!
Methods! and!Materials! section! can! be! found.! They!were!made! up! using! the! purest!
diH2O!(18.2)!to!ensure!that!there!were!no!contaminants!(e.g.!iron)!in!the!water.!
!
The! chemicals! and! other! ingredients! mentioned! here! were! purchased! from! SigmaL
Aldrich! Company! Ltd! or! Fisher! Scientific! UK! Ltd! unless! stated! otherwise.! Sterile! PBS!
was!purchased!from!the!School!of!Cancer!Sciences.!
!




For! a! standard! 10%! FCS! growth!medium,!DMEM!purchased! from! SigmaLAldrich!was!
supplemented!with! 50!ml! filter! sterilised! (0.2! μm)! FCS! (Biosera! or! PAA! Laboratories!
GmbH)! and! 5!ml! of! penicillinLstreptomycin! solution! (100! units/ml! penicillin! and! 0.1!





of!alginates! in!solution,! it!was!not!possible!to! filter!sterilise!the!stocks!before!adding!
them!to!cells.!Therefore,!before!weighting!out!the!alginate!powder,!the!scales,!spatula!
and!weighting! boats!were! cleaned!with! 70%! IMS! to! achieve! semiLsterile! conditions.!
Immediately!after!weighting!out!0.8!g!of!alginate,!the!weighting!boat!was!transferred!






by! shaking.! The! stocks! were! left! in! a! 37°C! incubator! until! the! alginates! were! fully!




























































SDS!were! dissolved! in! 900!ml! diH2O.! The! pH!was! adjusted! to! 8.3! with! HCl! and! the!


























































For! the!PSA!assay,! standards!were!needed! for!all! alginates.!Therefore,!0.3%!alginate!
stocks!were!prepared!by!dissolving!0.12!g!alginate!in!40!ml!diH2O!substituted!with!one!
drop!of!toluene.!This!stock!was!diluted!for!the!standards!as!follows:!
• Standard!1!L!0.015%! ! 1!ml!in!19!ml!
• Standard!2!L!0.0125%!! 0.83!ml!in!19.17!ml!






















For! the! PSA! assay,! the! samples! were! diluted! in! SLS! /! DLS! water! 1:10! for! a! final!
concentration!of!0.002%!alginate.!
!
Following! the!PSA!assay,! the!samples!were!diluted!with! filtered!SLS!/!DLS!water! in!a!
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